Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKesson
Medtronic
Moodys
Express Scripts
Dow
AstraZeneca

Last Updated: December 6, 2019

DrugPatentWatch Database Preview

Details for Patent: 9,731,082

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,731,082
Title:Drug container
Abstract: The present invention relates to an assembly (101) comprising: an injection device (1) comprising a container (2) for a product, said container comprising a distal tip (3), an adaptor (5) comprising a ring (6) mounted onto said distal tip (3), characterized in that said assembly (101) further comprises a heat-shrinkable film (9) covering part (2a) of said container (2) and part (5a) of said adaptor (5), said film (9) maintaining said adaptor (5) blocked in rotation and in translation with respect to said container (2) when said film (9) is in its heat-shrunk condition. The invention further relates to a method for manufacturing such an assembly.
Inventor(s): Vernizeau; Michel (Valence, FR), Foucher; Cedric (Grenoble, FR), Lefebvre; Lionel (Varois et Chaignot, FR)
Assignee: Fresenius Kabi Deutschland GmbH (Bad Homburg, DE)
Application Number:13/132,285
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 9,731,082
Patent Claim Types:
see list of patent claims
Use; Device; Dosage form;

Drugs Protected by US Patent 9,731,082

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Fresenius Kabi Usa DILAUDID hydromorphone hydrochloride INJECTABLE;INJECTION 019034-003 Apr 30, 2009 AP RX Yes Yes   Start Trial   Start Trial Y   Start Trial
Fresenius Kabi Usa DILAUDID hydromorphone hydrochloride INJECTABLE;INJECTION 019034-004 Apr 30, 2009 AP RX Yes Yes   Start Trial   Start Trial Y   Start Trial
Fresenius Kabi Usa DILAUDID hydromorphone hydrochloride INJECTABLE;INJECTION 019034-005 Apr 30, 2009 DISCN Yes No   Start Trial   Start Trial Y   Start Trial
Fresenius Kabi Usa DILAUDID-HP hydromorphone hydrochloride INJECTABLE;INJECTION 019034-001 Jan 11, 1984 DISCN Yes No   Start Trial   Start Trial Y   Start Trial
Fresenius Kabi Usa DILAUDID-HP hydromorphone hydrochloride INJECTABLE;INJECTION 019034-002 Aug 4, 1994 DISCN No No   Start Trial   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 9,731,082

PCT Information
PCT FiledDecember 02, 2008PCT Application Number:PCT/IB2008/003736
PCT Publication Date:June 10, 2010PCT Publication Number: WO2010/064074

International Family Members for US Patent 9,731,082

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Denmark 2376147   Start Trial
European Patent Office 2376147   Start Trial
Spain 2693123   Start Trial
Hungary E041597   Start Trial
Japan 2012510330   Start Trial
Japan 5737692   Start Trial
World Intellectual Property Organization (WIPO) 2010064074   Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
McKesson
Baxter
Johnson and Johnson
Harvard Business School
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.